Table 1 Comparative results of the two studies
The first study (n = 1000) | The second study (n = 1000) | |||
|---|---|---|---|---|
Just before transition to family medicine | One year after transition to family medicine | |||
n | Coverage (%) | n | Coverage (%) | |
BCG | 989 | 98.9 | 985 | 98.5 |
BCG Scatris + | 982 | 98.2 | 972 | 97.2 |
Pentac-Hib 1 | 989 | 98.9 | 991 | 99.1 |
Pentac-Hib 2 | 983 | 98.3 | 975 | 97.5 |
Pentac-Hib 3 | 976 | 97.6 | 956 | 95.6 |
Pentac-hib booster | 599 | 59.9 | 652 | 65.2 |
Oral polio 1 | 978 | 97.8 | 938 | 93.8 |
Oral polio 2 booster | 597 | 59.7 | 630 | 63.0 |
Hepatititis B 1 | 990 | 99.0 | 998 | 99.8 |
Hepatititis B 2 | 987 | 98.7 | 986 | 98.6 |
Hepatititis B 3 | 977 | 97.7 | 954 | 95.4 |
MMR | 974 | 97.4 | 920 | 92.0 |
13v PCV 1 | 983 | 98.3 | 986 | 98.6 |
13v PCV 2 | 977 | 97.7 | 970 | 97.0 |
13v PCV 3 | 970 | 97.0 | 952 | 95.2 |
13v PCV booster | 926 | 92.6 | 883 | 88.3 |
Fully vaccinated | 937 | 93.7 | 840 | 84.0 |